AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 173 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,645,000 | -13.4% | 108,300 | +14.0% | 0.02% | +7.1% |
| Q3 2018 | $1,900,000 | -22.2% | 95,000 | -21.6% | 0.01% | -41.7% |
| Q1 2018 | $2,442,000 | +2.3% | 121,200 | -32.7% | 0.02% | +14.3% |
| Q4 2017 | $2,388,000 | -17.8% | 180,200 | +14.5% | 0.02% | -19.2% |
| Q3 2017 | $2,904,000 | -4.8% | 157,400 | -5.0% | 0.03% | -10.3% |
| Q2 2017 | $3,049,000 | -57.4% | 165,700 | -47.8% | 0.03% | -14.7% |
| Q1 2017 | $7,152,000 | +88.7% | 317,200 | +191.3% | 0.03% | -26.1% |
| Q4 2016 | $3,790,000 | -11.9% | 108,900 | -37.9% | 0.05% | -2.1% |
| Q3 2016 | $4,302,000 | -15.2% | 175,500 | -17.2% | 0.05% | -17.5% |
| Q2 2016 | $5,071,000 | +6.7% | 212,000 | +4.4% | 0.06% | +7.5% |
| Q1 2016 | $4,753,000 | -35.1% | 203,100 | -15.4% | 0.05% | -44.2% |
| Q4 2015 | $7,326,000 | – | 240,200 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |